(C) World Health Organization
This story was originally published by World Health Organization and is unaltered.
. . . . . . . . . .
Webinar: WHO global research agenda for AMR in human health [1]
[]
Date: 2023-06-22
Thursday 22 June 2023
12:00-13:30 (CEST)
Background
The global research agenda for AMR in human health aims to catalyze research on the burden and impact of AMR, strategies to prevent infections and development of resistance, the discovery and development of new diagnostics and better treatment regimens, and how to optimize the use of current tools and implement them more efficiently. Ultimately, it aims to inform evidence-based policies and interventions to strengthen the AMR response, especially in low-and-middle-income countries (LMICs).
The research agenda was developed following a rigorous and transparent process starting with a scoping review of over 3,000 documents in the past 10 years which generated 2,340 knowledge gaps. Following several rounds of review and consolidation of these knowledge gaps into research questions, over 230 experts globally across a range of disciplines related to AMR research scored the questions against five criteria in a transparent, independent and reproducible approach. This enabled the identification of global AMR research priorities for human health by 2030.
Agenda
Opening remarks: Dr Hanan Balkhy, Assistant Director-General, Antimicrobial Resistance Division, WHO
Dr Hanan Balkhy, Assistant Director-General, Antimicrobial Resistance Division, WHO The global research agenda for AMR: priorities for research in human health by 2030: Dr Silvia Bertagnolio, Unit Head, Antimicrobial Resistance Division, WHO
Dr Silvia Bertagnolio, Unit Head, Antimicrobial Resistance Division, WHO Commentary and reflections from speakers: Priorities for research on resistant tuberculosis: Professor Claudia M. Denkinger, Head of Division of Infectious Disease and Tropical Medicine, Heidelberg University Hospital (UKHD), Germany Prevention of infections: Dr Tochi Okwor, Chair Nigeria Antimicrobial Resistance Coordination Committee (AMR) and Infection Prevention and Control (IPC) Programme Coordinator, Nigeria Centre for Disease Control and Prevention Diagnosis of bacterial infections: Professor Till Bachmann, Professor and Chair of Molecular Diagnostics and Infection, University of Edinburgh, United Kingdom Treatment and care: Professor Céline Pulcini, Université de Lorraine - CHRU Nancy, France Priorities for research on critical fungi: Professor Nelesh Govender, National Institute for Communicable Diseases and University of the Witswatersrand (WHO CC for AMR), South Africa, and Dr Ana Alastruey-Izquierdo, Instituto de Salud Carlos III, Spain Translating research into action: Laura Marin, Head of Secretariat, European Commission Joint Programming Initiative on Antimicrobial Resistance, Swedish Research Council, Coordinator CSA DESIGN OH AMR
Closing remarks : Professor Sabiha Essack, School of Pharmaceutical Sciences at the University of KwaZulu-Natal
: Professor Sabiha Essack, School of Pharmaceutical Sciences at the University of KwaZulu-Natal The session will be moderated by Professor Sabiha Essack
Interpretation into French and Spanish will be available.
[END]
---
[1] Url:
https://www.who.int/news-room/events/detail/2023/06/22/default-calendar/webinar--the-global-amr-research-agenda-in-human-health
Published and (C) by World Health Organization
Content appears here under this condition or license: Creative Commons CC-BY-NC-SA 3.0 IGO.
via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/who/